Theseus Pharmaceuticals Statistics
Total Valuation
MATW has a market cap or net worth of $726.05 million. The enterprise value is $1.41 billion.
Important Dates
The last earnings date was Tuesday, August 5, 2025, after market close.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | Aug 11, 2025 |
Share Statistics
MATW has 30.79 million shares outstanding. The number of shares has decreased by -0.97% in one year.
Current Share Class | 30.79M |
Shares Outstanding | 30.79M |
Shares Change (YoY) | -0.97% |
Shares Change (QoQ) | +0.75% |
Owned by Insiders (%) | 4.90% |
Owned by Institutions (%) | 80.51% |
Float | 29.27M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 32.98 |
PS Ratio | 0.45 |
Forward PS | 1.15 |
PB Ratio | 1.44 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | 351.60 |
PEG Ratio | 4.40 |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.87 |
EV / EBITDA | 8.00 |
EV / EBIT | 14.79 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 1.37.
Current Ratio | 1.66 |
Quick Ratio | 0.58 |
Debt / Equity | 1.37 |
Debt / EBITDA | 3.99 |
Debt / FCF | n/a |
Interest Coverage | 1.57 |
Financial Efficiency
Return on equity (ROE) is -12.81% and return on invested capital (ROIC) is 4.55%.
Return on Equity (ROE) | -12.81% |
Return on Assets (ROA) | 3.34% |
Return on Invested Capital (ROIC) | 4.55% |
Return on Capital Employed (ROCE) | 6.82% |
Revenue Per Employee | $147,777 |
Profits Per Employee | -$5,924 |
Employee Count | 11,000 |
Asset Turnover | 0.91 |
Inventory Turnover | 4.55 |
Taxes
In the past 12 months, MATW has paid $39.07 million in taxes.
Income Tax | 39.07M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.64% in the last 52 weeks. The beta is 1.23, so MATW's price volatility has been higher than the market average.
Beta (5Y) | 1.23 |
52-Week Price Change | -7.64% |
50-Day Moving Average | 23.54 |
200-Day Moving Average | 24.43 |
Relative Strength Index (RSI) | 47.01 |
Average Volume (20 Days) | 207,280 |
Short Selling Information
The latest short interest is 1.47 million, so 4.77% of the outstanding shares have been sold short.
Short Interest | 1.47M |
Short Previous Month | 1.54M |
Short % of Shares Out | 4.77% |
Short % of Float | 5.02% |
Short Ratio (days to cover) | 6.75 |
Income Statement
In the last 12 months, MATW had revenue of $1.63 billion and -$65.16 million in losses. Loss per share was -$2.10.
Revenue | 1.63B |
Gross Profit | 580.82M |
Operating Income | 95.20M |
Pretax Income | 13.19M |
Net Income | -65.16M |
EBITDA | 176.10M |
EBIT | 95.20M |
Loss Per Share | -$2.10 |
Full Income Statement Balance Sheet
The company has $20.38 million in cash and $702.50 million in debt, giving a net cash position of -$682.12 million or -$22.15 per share.
Cash & Cash Equivalents | 20.38M |
Total Debt | 702.50M |
Net Cash | -682.12M |
Net Cash Per Share | -$22.15 |
Equity (Book Value) | 513.83M |
Book Value Per Share | 16.35 |
Working Capital | 205.53M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $2.07 million and capital expenditures -$38.43 million, giving a free cash flow of -$36.36 million.
Operating Cash Flow | 2.07M |
Capital Expenditures | -38.43M |
Free Cash Flow | -36.36M |
FCF Per Share | -$1.18 |
Full Cash Flow Statement Margins
Gross margin is 35.73%, with operating and profit margins of 5.86% and -4.01%.
Gross Margin | 35.73% |
Operating Margin | 5.86% |
Pretax Margin | -1.61% |
Profit Margin | -4.01% |
EBITDA Margin | 10.83% |
EBIT Margin | 5.86% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.00, which amounts to a dividend yield of 4.24%.
Dividend Per Share | $1.00 |
Dividend Yield | 4.24% |
Dividend Growth (YoY) | 4.17% |
Years of Dividend Growth | 27 |
Payout Ratio | n/a |
Buyback Yield | 0.97% |
Shareholder Yield | 5.21% |
Earnings Yield | -8.97% |
FCF Yield | -5.01% |
Dividend Details Analyst Forecast
The average price target for MATW is $40.00, which is 69.64% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $40.00 |
Price Target Difference | 69.64% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on September 4, 2001. It was a forward split with a ratio of 2:1.
Last Split Date | Sep 4, 2001 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |